# Role of Perfluorobutane in Lesion Detection, Targeting and Response Assessment for Ablation of HCC

> **NCT05068076** · NA · COMPLETED · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 21 (actual)

## Conditions studied

- Hepatocellular Carcinoma
- Microwave Ablation

## Interventions

- **DRUG:** Perfluorobutane

## Key facts

- **NCT ID:** NCT05068076
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-01
- **Primary completion:** 2021-12-16
- **Final completion:** 2021-12-16
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2021-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05068076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05068076, "Role of Perfluorobutane in Lesion Detection, Targeting and Response Assessment for Ablation of HCC". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05068076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*